{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:06:54Z","timestamp":1768003614197,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T00:00:00Z","timestamp":1350864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T00:00:00Z","timestamp":1350864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/bmt.2012.198","type":"journal-article","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T10:46:31Z","timestamp":1350902791000},"page":"732-733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Delayed graft-versus-mast-cell effect on systemic mastocytosis with associated clonal haematological non-mast cell lineage disease after allogeneic transplantation"],"prefix":"10.1038","volume":"48","author":[{"given":"T","family":"Gromke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A H","family":"Elmaagacli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Ditschkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Hegerfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Koldehoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Hlinka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Ottinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Trenschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D W","family":"Beelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,22]]},"reference":[{"key":"BFbmt2012198_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/sj.bmt.1705245","volume":"37","author":"R Nakamura","year":"2006","unstructured":"Nakamura R, Chakrabarti S, Akin C, Robyn J, Bahceci E, Greene A et al. A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis. Bone Marrow Transplant 2006; 37: 353\u2013358.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012198_CR2","first-page":"413","volume":"8","author":"D R\u00f8nnov-Jessen","year":"1991","unstructured":"R\u00f8nnov-Jessen D, L\u00f8vgreen Nielsen P, Horn T . Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome. Bone Marrow Transplant 1991; 8: 413\u2013415.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012198_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s12185-008-0166-4","volume":"88","author":"L Pagano","year":"2008","unstructured":"Pagano L, Valentini CG, Caira M, Rondoni M, Van Lint MT, Candoni A et al. Advanced mast cell disease: an Italian hematological multicenter experience. Int J Hematol 2008; 88: 483\u2013488.","journal-title":"Int J Hematol"},{"key":"BFbmt2012198_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","volume":"27","author":"P Valent","year":"2003","unstructured":"Valent P, Akin C, Sperr WR, Escribano L, Arock M, Horny HP et al. Aggressive systemic mastocytosis and related mast cell disorders: current treatment in options and proposed response criteria. Leuk Res 2003; 27: 635\u2013641 (review).","journal-title":"Leuk Res"},{"key":"BFbmt2012198_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.bmt.1702659","volume":"26","author":"G Chong","year":"2000","unstructured":"Chong G, Byrnes G, Szer J, Grigg A . Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy. Bone Marrow Transplant 2000; 26: 1011\u20131015 (review).","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012198_CR6","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s001050050958","volume":"50","author":"D Ludolph-Hauser","year":"1999","unstructured":"Ludolph-Hauser D, Ru\u00ebff F, Sommerhoff CP, Przybilla B . Tryptase a marker for the activation and localization of mast cells. Hautarzt 1999; 50: 556\u2013561 (review; German).","journal-title":"Hautarzt"},{"key":"BFbmt2012198_CR7","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2214\/ajr.179.5.1791235","volume":"179","author":"G Zettinig","year":"2002","unstructured":"Zettinig G, Becherer A, Szabo M, Uffmann M, Dudczak R, Valent P et al. FDG positron emission tomography in patients with systemic mastocytosis. AJR Am J Roentgenol 2002; 179: 1235\u20131237.","journal-title":"AJR Am J Roentgenol"},{"key":"BFbmt2012198_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1740-8261.2009.01520.x","volume":"50","author":"AK LeBlanc","year":"2009","unstructured":"LeBlanc AK, Jakoby BW, Townsend DW, Daniel GB . 18FDG-PET imaging in canine lymphoma and cutaneous mast cell tumor. Vet Radiol Ultrasound 2009; 50: 215\u2013223.","journal-title":"Vet Radiol Ultrasound"},{"issue":"Part 2","key":"BFbmt2012198_CR9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0091-6749(99)70156-9","volume":"1003","author":"M Kurosawa","year":"1999","unstructured":"Kurosawa M, Amano H, Kanbe N, Igarashi Y, Nagata H, Yamashita T et al. Response to cyclosporin and low-dose methylprednisolone in aggressive systemic mastocytosis. J Allergy Clin Immunol 1999; 1003 (Part 2): 412\u2013420.","journal-title":"J Allergy Clin Immunol"},{"key":"BFbmt2012198_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0889-8588(05)70301-4","volume":"14","author":"AS Worobec","year":"2000","unstructured":"Worobec AS . Treatment of systemic mast cell disorders. Hematol Oncol Clin North Am 2000; 14: 659\u2013687 (vii; review).","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2012198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012198","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T15:14:35Z","timestamp":1648048475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2012198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,22]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["BFbmt2012198"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2012.198","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,22]]},"assertion":[{"value":"22 October 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}